Mark Stenhouse

Insider Reports History

Entity
Individual
Location
5505 Endeavor Lane, Madison, WI
Signature
/s/ Molly Henderson, Attorney-in-Fact for Mark Stenhouse
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Stenhouse:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Phathom Pharmaceuticals, Inc. Director Common Stock 19.5K $178K $9.11 May 23, 2024 Direct
Phathom Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 17.5K May 23, 2024 Direct
Prometheus Biosciences, Inc. Chief Operating Officer Common Stock 0 $108.42 Jun 16, 2023 By Stenhouse Family Fund
Prometheus Biosciences, Inc. Chief Operating Officer Common Stock 0 $108.42 Jun 16, 2023 Direct
Prometheus Biosciences, Inc. Chief Operating Officer Stock Option (right to buy) 0 Jun 16, 2023 Direct

Insider Reports Filed by Mark Stenhouse

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PHAT Phathom Pharmaceuticals, Inc. May 23, 2024 2 $0 4 May 24, 2024 Director
RXDX Prometheus Biosciences, Inc. Jun 16, 2023 7 $0 4 Jun 16, 2023 Chief Operating Officer
RXDX Prometheus Biosciences, Inc. Jun 1, 2023 2 $0 4 Jun 2, 2023 Chief Operating Officer
PHAT Phathom Pharmaceuticals, Inc. May 25, 2023 2 $0 4 May 30, 2023 Director
RXDX Prometheus Biosciences, Inc. Dec 9, 2022 2 $0 4 Dec 13, 2022 Chief Operating Officer
PHAT Phathom Pharmaceuticals, Inc. May 25, 2022 1 $0 4 May 27, 2022 Director
RXDX Prometheus Biosciences, Inc. May 20, 2022 1 $0 4 May 20, 2022 Chief Operating Officer
RXDX Prometheus Biosciences, Inc. Nov 14, 2021 1 $0 4 Nov 16, 2021 Chief Operating Officer
PHAT Phathom Pharmaceuticals, Inc. May 21, 2021 1 $0 4 May 24, 2021 Director